Home|Journals|Articles by Year|Audio Abstracts
 

Research Article



Antitumor Activity of Erythrina Indica Leaf Extract in Human Lung Cancer Cells

MOULISHREE RAMESH, S.RAGHUNANDHAKUMAR, D.EZHILARASAN, LAKSHMI T.




Abstract

Over the few decades, lung cancer has appeared to be a global threat as globalisation improved worldwide. There are various risk factors which keep increasing, making the incidence and pathogenesis of lung cancer more complex. This study focuses on erythrina Indica lam. extract which has been believed to have various pharmaceutical effects based on their numerous phytochemical constituents. The aim of the study is to determine the antitumor activity of erythrina Indica lam. Leaf extract in human lung cancer cells. The effect of Erythrina Indica lam. From the cell viability experiment, the erythrina indica lam extract showed 50% cell growth inhibitory effect at 100μg/ ml (IC50) against the human lung cancer cells. Thus, there exists a significant antitumor activity of erythrina Indica lam. Extract, precisely at 100μg/ml, shows maximum potential inhibiting 50% of human lung cancer cells. Further studies should be done focusing the antitumor activity of the erythrina leaf extract, with any possibilities of side effects caused to make it as a natural alternative medication.

Key words: Antitumor, Erythrina Indica, Lung Cancer, Leaf Cancer, Leaf Extract, MTT Assay, Innovative Technology.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.